| Name | Title | Contact Details |
|---|
Instrumentation Laboratory is a Lexington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Dthera™ Sciences (OTCQB:DTHR) is the leading digital therapeutic company focusing on the elderly. The San Diego-based, publicly traded company is working to improve the lives of seniors and individuals suffering from neurodegenerative diseases, as well as those who care for them. It has two core products: ReminX™, a commercially available consumer health product for individuals suffering from social isolation and dementia; and DTHR-ALZ, and a development-stage product that has been granted Breakthrough Device designation by the FDA for the mitigation of the symptoms of agitation and depression associated with Alzheimer`s disease.
NeoSync is a clinical-stage company with a proprietary platform technology being used to develop advanced, non-invasive neuromodulation products.
ApiJect Systems, Corp. is reimagining how injectable medicines can be packaged and delivered to the world. ApiJect`s technology platform is based on a design philosophy of basic interlocking components to create simple and highly-scalable drug delivery devices. Our first product is the ApiJect Prefilled Injector, a single-dose parenteral that is manufactured in two parts: a Blow-Fill-Seal (BFS) Container aseptically filled with medicine or vaccine, and an insulin-style Needle Hub, also made by ApiJect. At the point of care, a healthcare worker attaches these two components in seconds to activate the injector. By using high-speed, high-volume Blow-Fill-Seal plastics technology, we can reliably supply millions of aseptically filled prefilled injectors per month. Simple devices like these will enable ApiJect to fulfill its mission of making injectable medicines safe and available for everyone.
EndoStim is a medical device company focused on the treatment of gastroesophageal reflux disease (GERD) through electrical stimulation of the lower esophageal sphincter. GERD is a condition affects millions of people worldwide and is often not optimally treated despite a maximum drug dosage of medications such as proton pump inhibitors (PPIs). EndoStim’s innovative technology provides a solution addressing the root physiological cause of the disease -- namely a weak or dysfunctional lower esophageal sphincter that allows for reflux into the esophagus.